Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
AKT1
Name:
AKT serinethreonine kinase 1
Location:
14q32.33
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT01075373 | A Neurobiological Study on Heterogeneity of Schizophrenia Genetic Variations and Neurobiological Differentiations | View | |
| NCT04316546 | MK-7075 Miransertib in Proteus Syndrome | View | |
| NCT05455619 | Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Women With a PI3K Alteration and HRHer2- Breast Cancer | View | |
| NCT02476955 | Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole | View | |
| NCT01915576 | Phase I Dose Escalation Study With an Allosteric AKT 12 Inhibitor in Patients | View | |
| NCT01473095 | Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma | View | |
| NCT01226316 | Safety Tolerability Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules | View | |
| NCT03310541 | AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations | View | |
| NCT02331966 | Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia | View | |
| NCT06533059 | A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors | View | |
| NCT02594215 | Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome | View | |
| NCT02761694 | Vevorisertib ARQ 751 as a Single Agent or in Combination With Other Anti-Cancer Agents in Solid Tumors With PIK3CA AKT PTEN Mutations MK-4440-001 | View | |
| NCT03017521 | K-BASKET TAS-117 PI3KAKT Gene Aberration | View | |
| NCT03318263 | CIrCuLAting Dna ESr1 Gene Mutations Analysis | View |